11
From Europe to National level: evidence-based policies Marc Van den Bulcke 19 November 2014 Rue Juliette Wytsmanstraat 14 | 1050 Brussels | Belgium T +32 2 642 51 11 | F +32 2 642 50 01 | email: [email protected] | www.wiv-isp.be

From Europe to National level: evidence-based policies Marc Van den Bulcke 19 November 2014 Rue Juliette Wytsmanstraat 14 | 1050 Brussels | Belgium T +32

Embed Size (px)

Citation preview

Page 1: From Europe to National level: evidence-based policies Marc Van den Bulcke 19 November 2014 Rue Juliette Wytsmanstraat 14 | 1050 Brussels | Belgium T +32

From Europe to National level:

evidence-based policies

Marc Van den Bulcke 19 November 2014

Rue Juliette Wytsmanstraat 14 | 1050 Brussels | BelgiumT +32 2 642 51 11 | F +32 2 642 50 01 | email: [email protected] | www.wiv-isp.be

Page 2: From Europe to National level: evidence-based policies Marc Van den Bulcke 19 November 2014 Rue Juliette Wytsmanstraat 14 | 1050 Brussels | Belgium T +32
Page 3: From Europe to National level: evidence-based policies Marc Van den Bulcke 19 November 2014 Rue Juliette Wytsmanstraat 14 | 1050 Brussels | Belgium T +32

Cancer Plan in Belgium (2008):

General organisation:

- 3 domains: ‘Prevention and Screening’, ‘Care’, ‘Research and Innovation’

- 32 actions covering 78 measures

- managed by the Ministries of Public Health and Social Affairs and followed up by the Cancer Centre (in collaboration with an Advisory Board and a Coordination Platform)

Status of Implementation: by 2014, all actions have been addressed.

The Cancer Centre was installed in 2009.

Page 4: From Europe to National level: evidence-based policies Marc Van den Bulcke 19 November 2014 Rue Juliette Wytsmanstraat 14 | 1050 Brussels | Belgium T +32

Action 29: Translational research

60 projects in period 2009-2015

human in vitro in vivo patients0

10

20

30

40

50

60

Total

Total

Page 5: From Europe to National level: evidence-based policies Marc Van den Bulcke 19 November 2014 Rue Juliette Wytsmanstraat 14 | 1050 Brussels | Belgium T +32

Cancer Plan & the 5 TWGs

Call for5 Thematic Work Groups

1. Rehabilitation2. Hospital – home care3. Stem cells4. Quality system5. Personalised Medicine

www.wiv-isp.be/cancer

Page 6: From Europe to National level: evidence-based policies Marc Van den Bulcke 19 November 2014 Rue Juliette Wytsmanstraat 14 | 1050 Brussels | Belgium T +32

Thematic Working Group 5 ‘Personalized Medicine’

NGS in the CLINIC – Targeted Therapies

Page 7: From Europe to National level: evidence-based policies Marc Van den Bulcke 19 November 2014 Rue Juliette Wytsmanstraat 14 | 1050 Brussels | Belgium T +32

Today, the cost of sequencing a human genome using these NGS technologies has dipped to just under $8,000

Page 8: From Europe to National level: evidence-based policies Marc Van den Bulcke 19 November 2014 Rue Juliette Wytsmanstraat 14 | 1050 Brussels | Belgium T +32

WG: Evidence-based NGS panels

Page 9: From Europe to National level: evidence-based policies Marc Van den Bulcke 19 November 2014 Rue Juliette Wytsmanstraat 14 | 1050 Brussels | Belgium T +32
Page 10: From Europe to National level: evidence-based policies Marc Van den Bulcke 19 November 2014 Rue Juliette Wytsmanstraat 14 | 1050 Brussels | Belgium T +32

The NGS workflow

Page 11: From Europe to National level: evidence-based policies Marc Van den Bulcke 19 November 2014 Rue Juliette Wytsmanstraat 14 | 1050 Brussels | Belgium T +32

THANK YOU